sb 203580 has been researched along with Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, CL; Menon, R; Richardson, L; Saade, G; Sheller-Miller, S | 1 |
| Ayala, A; Chaudry, IH; Chung, CS; Song, GY | 1 |
2 other study(ies) available for sb 203580 and Infection
| Article | Year |
|---|---|
A distinct mechanism of senescence activation in amnion epithelial cells by infection, inflammation, and oxidative stress.
Topics: Amnion; Cells, Cultured; Cellular Senescence; Epithelial Cells; Extraembryonic Membranes; Female; Humans; Imidazoles; Infections; Inflammation; Interleukin-6; Lipopolysaccharides; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pregnancy; Premature Birth; Primary Cell Culture; Pyridines; Tumor Necrosis Factor-alpha | 2018 |
MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis.
Topics: Animals; Cyclooxygenase 2; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Imidazoles; Immune Tolerance; Immunity; Immunity, Cellular; Infections; Interleukin-10; Interleukin-2; Interleukin-4; Isoenzymes; Lymphocytes; Lymphoid Tissue; Male; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines | 2001 |